| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | 1 | — | 1 | — | — | — | 1 | — |
| total | individual payouts | |
|---|---|---|
| 2028 | ‡‡‡‡ |
|
| 2027 | ‡‡‡‡‡ |
|
| 2026 | 2.06 |
—
—
—
|
| 2025 | 1.94 |
—
—
—
—
|
| 2024 | 1.79 |
—
—
—
—
|
| 2023 | 1.62 |
—
—
—
—
|
| 2022 | 1.47 |
—
—
—
—
|
| 2021 | 1.33 |
—
—
—
—
|
| 2020 | 1.20 |
—
—
—
—
|
| 2019 | 1.09 |
—
—
—
—
|
| 2018 | 0.96 |
—
—
—
—
|
| 2017 | 0.82 |
—
—
—
—
|
| 2016 | 0.72 |
—
—
—
—
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 1,810.00 | 1,351.00 | 2,125.00 | 1,716.00 |
| Receivables | 4,512.00 | 4,811.00 | 4,858.00 | 5,008.00 |
| Inventory | 3,615.00 | 3,827.00 | 4,419.00 | 4,405.00 |
| Other | 1,766.00 | 3,253.00 | 1,549.00 | 1,809.00 |
| 11,703.00 | 13,242.00 | 12,951.00 | 12,938.00 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 8,321.00 | 9,433.00 | 10,139.00 | 9,411.00 |
| ST’ Debt | 2,101.00 | 2,014.00 | 1,295.00 | 2,663.00 |
| Other | 4,330.00 | 4,545.00 | 3,955.00 | 3,705.00 |
| 19,013.00 | 19,549.00 | 21,864.00 | 21,593.00 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 10,080.00 | 9,355.00 | — | — |
—
|
| ’25 | 9,313.00 | 8,984.00 | 9,744.00 | 10,496.00 |
38,537.00
|
| ’24 | 9,290.00 | 8,343.00 | 9,204.00 | 9,604.00 |
36,441.00
|
| ’23 | 9,166.00 | 8,507.00 | 9,029.00 | 9,314.00 |
36,016.00
|
| ’22 | 7,764.00 | 7,274.00 | 7,763.00 | 8,695.00 |
31,496.00
|
| ’21 | 7,238.00 | 6,642.00 | 7,182.00 | 7,658.00 |
28,720.00
|
| ’20 | 6,707.00 | 5,911.00 | 6,665.00 | 7,298.00 |
26,581.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 467.00 | 855.00 | — | — |
—
|
| ’25 | 1,092.00 | 308.00 | 717.00 | 2,397.00 |
4,514.00
|
| ’24 | 1,324.00 | 822.00 | 1,305.00 | 1,459.00 |
4,910.00
|
| ’23 | 1,123.00 | 850.00 | 1,177.00 | 1,564.00 |
4,714.00
|
| ’22 | 1,131.00 | 836.00 | 549.00 | 1,392.00 |
3,908.00
|
| ’21 | 915.00 | 877.00 | 928.00 | 1,421.00 |
4,141.00
|
| ’20 | 284.00 | 1,274.00 | 757.00 | 1,649.00 |
3,964.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 155.00 | 516.00 | — | — |
—
|
| ’25 | 816.00 | 10.00 | 418.00 | 2,000.00 |
3,244.00
|
| ’24 | 1,027.00 | 468.00 | 990.00 | 1,054.00 |
3,539.00
|
| ’23 | 914.00 | 674.00 | 802.00 | 1,231.00 |
3,621.00
|
| ’22 | 1,042.00 | 540.00 | 917.00 | 548.00 |
3,047.00
|
| ’21 | 715.00 | 667.00 | 2,197.00 | (189.00) |
3,390.00
|
| ’20 | 255.00 | 858.00 | 1,929.00 | 69.00 |
3,111.00
|
| Mar | Jun | Sep | Dec | Year | |
|---|---|---|---|---|---|
| ’26 | 0.44 | 1.20 | — | — |
—
|
| ’25 | 0.31 | 0.49 | 0.57 | 0.51 |
1.89
|
| ’24 | 1.04 | 0.45 | 0.63 | 1.30 |
3.42
|
| ’23 | 1.52 | 0.69 | 0.72 | 0.70 |
3.62
|
| ’22 | 0.61 | 0.54 | 0.39 | 0.42 |
1.96
|
| ’21 | 0.68 | 0.76 | 0.89 | 0.71 |
3.04
|
| ’20 | 0.52 | 0.38 | 0.78 | 0.80 |
2.47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 54.72 | 60.75 | 58.90 | 53.13 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 69.47 | 78.59 | 77.20 | 71.15 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 91,000 | 91,000 | 90,000 | 91,000 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.35 | 0.40 | 0.40 | 0.42 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 31,496.00 | 36,016.00 | 36,441.00 | 38,537.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.92% | 38.22% | 39.12% | 28.38% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,228.00 | 5,880.00 | 6,261.00 | 3,014.00 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.25% | 16.33% | 17.18% | 7.82% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,726.00 | 4,968.00 | 4,623.00 | 2,466.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,107.00 | 1,215.00 | 1,302.00 | 1,358.00 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.86 | 26.42 | 27.17 | 29.78 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 1.97 | 3.64 | 3.44 | 1.89 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.84 | 3.46 | 3.66 | 3.49 | ‡‡‡‡ | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.62) | (0.80) | (1.02) | (0.98) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.21 | 2.66 | 2.64 | 2.51 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 19.54 | 20.81 | 20.10 | 20.01 | ‡‡‡‡ | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,378.00 | 1,363.00 | 1,341.00 | 1,294.00 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.46 | 20.34 | 17.31 | 28.48 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.90 | 2.79 | 2.20 | 1.81 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.39 | 3.55 | 2.97 | 2.69 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.49 | 3.27 | 2.65 | 2.23 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 36.10 | 32.54 | 27.25 | 26.53 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,908.00 | 4,714.00 | 4,910.00 | 4,514.00 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (861.00) | (1,093.00) | (1,371.00) | (1,270.00) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,047.00 | 3,621.00 | 3,539.00 | 3,244.00 | ‡‡‡‡‡ | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (6,640.00) | (7,310.00) | (6,307.00) | (8,913.00) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 20,634.00 | 18,988.00 | 17,678.00 | 18,517.00 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18,711.00 | 17,178.00 | 16,327.00 | 16,392.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 26,920.00 | 28,366.00 | 26,958.00 | 25,891.00 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3.93% | 6.96% | 6.59% | 3.50% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.84% | 7.55% | 9.16% | 5.24% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.84% | 17.94% | 16.67% | 9.28% | — | — | — |
ROE
|
Mondelez International, the snack empire fueling our Oreo cravings and Cadbury indulgences, has delivered steady revenue growth of 41% from $25.9 billion in 2016 to $36.4 billion in 2024, with a reliable 4.6% CAGR driven by emerging market volumes, pricing power, and savvy acquisitions like Clif Bar and Ricolas. Efficiency shines through, with revenue per employee up 40% to $405,000 amid stable headcount, and analysts forecast a 13% revenue surge to $41.1 billion by 2027, boosted by buybacks shrinking shares 14%.
Profitability tells a resilient story—net income up 181% since 2016 to $4.62 billion in 2024 despite margin squeezes from cocoa spikes—while free cash flow per share holds strong at $2.50-$3.66, supporting debt reduction from $20.6 billion and dividends. The stock has mirrored fundamentals, climbing from 2016 lows but now trading at discounted multiples (PE 17x, PS 1.8x), hinting at undervaluation versus historical norms.
Wall Street eyes mild bullishness with 6% average upside to targets, potentially 20% if margins rebound to 38-40%, projecting EPS to $3.57 by 2028 amid premiumization and e-commerce tailwinds. No insider trades signal quiet confidence, but commodity volatility looms—making Mondelez a tasty hold for 8-10% annual returns in patient portfolios. Dive deeper for the full revenue-profit correlations and catalysts ahead.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.